Johnson Matthey (LON:JMAT) Insider Liam Condon Buys 14 Shares

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon acquired 14 shares of the firm’s stock in a transaction that occurred on Wednesday, December 10th. The shares were bought at an average cost of GBX 2,013 per share, for a total transaction of £281.82.

Liam Condon also recently made the following trade(s):

  • On Wednesday, November 12th, Liam Condon acquired 10 shares of Johnson Matthey stock. The stock was purchased at an average cost of GBX 2,165 per share, with a total value of £216.50.
  • On Friday, October 10th, Liam Condon acquired 12 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 2,079 per share, with a total value of £249.48.

Johnson Matthey Stock Up 0.3%

Shares of LON:JMAT traded up GBX 6 during midday trading on Thursday, hitting GBX 2,012. 7,776,148 shares of the stock were exchanged, compared to its average volume of 1,761,295. The business’s fifty day simple moving average is GBX 2,078.08 and its two-hundred day simple moving average is GBX 1,915.49. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. Johnson Matthey PLC has a 52-week low of GBX 1,131 and a 52-week high of GBX 2,198. The company has a market capitalization of £3.37 billion, a PE ratio of -30.53, a P/E/G ratio of 49,242.50 and a beta of 0.95.

Johnson Matthey (LON:JMATGet Free Report) last announced its earnings results on Thursday, November 20th. The company reported GBX 51.20 earnings per share (EPS) for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, research analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on JMAT. Deutsche Bank Aktiengesellschaft lifted their target price on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a report on Thursday, October 9th. Citigroup increased their target price on shares of Johnson Matthey from GBX 1,800 to GBX 2,100 and gave the stock a “neutral” rating in a research note on Tuesday, October 21st. Panmure Gordon reiterated a “buy” rating and issued a GBX 2,370 price objective on shares of Johnson Matthey in a report on Monday, November 24th. Berenberg Bank decreased their price target on Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating on the stock in a research note on Tuesday, November 25th. Finally, Jefferies Financial Group lifted their price target on shares of Johnson Matthey from GBX 2,200 to GBX 2,420 and gave the company a “buy” rating in a report on Tuesday, October 14th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Johnson Matthey presently has an average rating of “Moderate Buy” and a consensus price target of GBX 2,248.

Read Our Latest Stock Report on JMAT

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Read More

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.